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It is now well established that B lymphocytes use immunoglobulins as their surface 
receptors.  In  contrast,  the  nature  of antigen  recognition structures  on T  cells  still 
remains unresolved. Recent results obtained from many different experimental systems 
have provided supportive evidence suggesting that T  and B cells have certain similar 
structures  in their receptor components (1-3).  Most of this evidence is derived from 
studies  using anti-idiotypic antibodies  to  probe the structure  of T-cell  receptors.  It 
was found that exogenous administration of anti-idiotypic antibodies could suppress 
or  induce  T-  and/or  B-cell  function  (4-9).  In  addition,  in  vitro  treatment  of two 
subpopulations of T  cells,  namely suppressor T  cells  and cytolytic T  cells  with anti- 
idiotypic antiserum  and  complement results  in  a  complete loss of their suppressive 
activity and cytolytic ability, respectively (10-12). Thus, it has been postulated that 
T  and  B lymphocytes may use the same genetic information for the construction of 
part of their receptors. 
Many lines of evidence have provided information that within the T-cell family, 
discernible heterogenicity exists with respect not only to cell surface markers but also 
to effector functions (13). In the murine system, at least five different subpopulations 
of T  cells  have been identified by functional and cell surface characterization. These 
are suppressor T  cells  (Lyt2+3  +, I-a+), cytotoxic T  cells  (Lyt2+3  +, I-a-), T  cells which 
mediate  delayed-type  hypersensitivity  (DTH) 1  (Lytl+),  feedback  inducer  T  ceils 
(Lytl+2+3+), and  helper T  cells  (Lyt 1+). In addition  it  has also been  demonstrated 
that  different T-cell subpopulations recognize antigenic determinants  in association 
with  different  regions  of  their  own  major  histocompatibility  complexes  (MHC). 
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Cytotoxic T  cells (To)  interact optimally with antigen and K  and/or D  regions of the 
MHC  (14,  15) on relevant target cells. T  cells which mediate delayed-type hypersen- 
sitivity  (TDn)  (16)  and  helper  T  cells  (17)  recognize  antigen  in  association  with  I 
region-encoded determinants.  Furthermore,  Lonai and co-workers (18)  had reported 
that  antigen  binding  to  Lyt-1 +  cells  was  inhibited  by anti-VH  antiserum,  whereas 
antigen binding to Lyt2+3  + ceils were inhibited  by anti-VL specifically. 
Based on these observations, we have undertaken  to investigate the expression of 
receptors  in  these  various  T-cell  subpopulations  using  a  simple  and  well-defined 
antigen.  We  have  studied  DTH  reactivity  to p-azobenzenearsonate  (ABA)  in  mice 
and its regulation. Extensive information is available concerning the humoral immune 
response to ABA (19). In our earlier studies, we have demonstrated that anti-idiotypic 
antibodies  to  the  major  cross-reactive  idiotype  (CRI)  associated  with  anti-ABA 
antibodies  in  A/J  mice,  when  injected  intravenously  into  normal  A/J  mice  will 
stimulate ABA-specific suppressor T-cell responses (20). Moreover, these suppressor T 
cells bear CRI idiotypic determinants  on their surface.  2 
In this report, we will present evidence that the anti-CRI antibodies when passively 
administered  to A/J mice under appropriate conditions will result in induction of T- 
cell-mediated immunity rather than suppression. Thus, anti-CRI antibodies also can 
activate immune TDH cells. The importance of this finding will be discussed in terms 
of the  role  of idiotype  and  anti-idiotype  interaction  in  the  regulation  of T-cell 
responses. 
Materials  and Methods 
Mice.  A/J (H-2  a, Igh-1  e) and BALB/c (H-2  a, Igh-I  a) female mice were obtained from The 
Jackson Laboratory, Bar Harbor, Maine.  C.AL20 (H-2  a, Igh-l~  female mice were obtained 
from breeding colonies established  at Brandeis University. The C.AL20 strain was originally 
produced by Michael Potter at the National Institutes of Health, Bethesda, Md. All animals 
used  in  these  experiments  were  8-10  wk  of age  at  the  time  of the  experiment  and  each 
experimental group consisted of at least  four mice. 
Preparation of  Anti-Idiotypic Antibodies.  Anti-idiotypic antibodies against the CRI characteristic 
of the anti-ABA antibodies of A/J mice were prepared and quantitated  as described earlier 
(21). Preparation of the F(ab)z fragments of the anti-CRI antibodies has also been described 
elsewhere  (22). 
Preparation of Antigen and Antigen-coupled Cells.  The diazonium salt ofp-arsanilic acid (East- 
man Organic Chemicals Div., Eastman Kodak Co., Rochester, N. Y.) was prepared as described 
earlier (23). A 40-mM solution was activated as previously described and conjugated to single 
cell suspensions oferythrocyte-free splenocytes at a final concentration of 10 mM. After washing 
in Hanks' balanced salt solution, the ABA-coupled cells were used to induce DTH or suppressor 
T cells as previously described (23). 
Induction of DTH to ABA with Anti-CRI Antibodies.  To induce DTH to ABA, various amount 
of anti-CRI antibodies in a 0.2-ml volume were injected subcutaneously into two separate sites 
on the dorsal flanks of mice. Challenge was performed 5 d later by injecting into the left footpad 
25 btl of 10 mM diazonium salt ofp-arsanilic acid. 24 h after footpad challenge, DTH reactivity 
was assessed by measuring the swelling of the footpad using a Fowler micrometer (Schlesinger's 
Tool, Brooklyn, N. Y.). The magnitude of the DTH reaction was expressed as the increment of 
thickness of the challenged left footpad as compared with the untreated right footpad. Response 
are given in units of 10  -4 inches ±  SEM. 
Elicitation with 2,4-dinitro-1-fluorobenzene (DNFB)  (Sigma Chemical Co., St.  Louis, Mo.) 
was done by applying 20/d of a 0.2% of DNFB in acetone-olive oil (4:1) solution on the dorsal 
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surfa~ze of each  ear and  increased ear swelling was  measured  24  h  later with  a  Mitutoya 
engir~eer's  micrometer (Schlesinger's Tool) and is expressed in units of 10 -4 inches +  SEM. 
Statistical analysis of the data obtained used the two-tailed Student's t test. 
Transfer of Immunity.  Animals which  had  been  immunized  with  ABA-coupled Syngeneic 
spleen cells (ABA-SC) or anti-idiotypic antibodies 4 d earlier were sacrificed. Draining lymph 
nodes from such animals were removed and a single cell suspension was prepared. 
The cells were washed twice in HBSS and counted, and 30 x  10  n viable cells in 0.5 ml were 
injected intravenously into normal recipients. Control mice received either no cells or cells from 
normal  donors.  The  recipients  and  control  mice  were  then  challenged  in  the  footpad  as 
described earlier within  1 h after cell transfer. 
Anti-O and Anti-CRI Serum Treatment.  Anti-Thy 1.2 hybridoma antiserum were obtained from 
Dr. P. Lake, University College, London. Briefly, 1 ×  108 cells were incubated with 1 ml of 1: 
20 dilution of anti-Thy 1.2 hybridoma antiserum or 25/tg of idiotype binding capacity (IBC) 
of the anti-CRI antibodies in 1 ml for 45 min at 0°C, washed once in HBSS and then incubated 
again  with  1 ml  of a  1:10  dilution of Low  Tox  rabbit  complement  (Cedarlane,  London, 
Ontario) for 30 min at 37°C. The cells were then washed twice in HBSS and resuspended for 
cell transfer. 
Induction of Suppressor TCells, with ABA-SC.  ABA-SC were prepared as described earlier (23). 
5  X  10  7  ABA-SC were  injected  intravenously  in  a  0.5-ml  volume  into  naive  A/J  recipi- 
ents. 7 d later spleens from such animals were removed and a single cell suspension was pre- 
pared  in  HBSS.  The  cells were  washed  twice  in  HBSS,  counted  and  5  ×  107  viable cells 
were then injected intravenously into normal recipients. The recipients and control animals 
were then immunized with anti-CRI antibodies subcutaneously within 1 h after cell transfer as 
described earlier. 
Cyclophosphamide  Treatment.  Mice were  injected intraperitonally with  50  mg/kg of cyclo- 
phosphamide (Mead Johnson and Co., Evansville, Ind.) diluted in distilled water. 
Results 
Induction  of DTH  to ABA  in Cyclophosphamide-pretreated  Animals with Anti-CRI Antibod- 
ies.  In earlier studies, we had demonstrated that  intravenous injection of anti-CRI 
antibodies preferentially activates suppressor T  cells (20). Furthermore, pretreatment 
of animals  with  low  doses of cyclophosphamide  (Cy)  eliminated  the  ability of the 
anti-CRI antibodies to induce suppression  (20).  However, it is now well established 
that the outcome of many immunological responses depends upon the doses of antigen 
employed, the manner it is administered, and the status of the host. We investigated 
whether by lowering the doses of anti-CRI antibodies, changing the route of admin- 
istration or by pretreating the animals with low doses of Cy we could induce immunity 
with anti-CRI antibodies. 
Animals were either pretreated with 50 mg/kg Cy or saline, and then 2 d  later they 
were  injected  with  various  doses  of  anti-CRI  antibodies  intravenously.  5  d  after 
immunization, the animals were challenged in the footpad with diazonium salt ofp- 
arsanilic acid, and DNFB on the ears as described in Materials and Methods. Increase 
in footpad and ear swelling was measured 24 h  after challenge. 
The  results of such  an  experiment  were shown  in  Fig.  1.  Animals not  pretreated 
with Cy failed to manifest any significant immunity over a  wide range of anti-CRI 
antibodies used for priming. However, in animals pretreated with Cy 2 d  earlier, as 
little as 0.1  /tg of IBC  induced significant DTH  reaction.  In addition, because both 
groups of animals failed to respond to challenge with DNFB it can be concluded that 
the immunity induced with anti-CRI antibodies is antigen-specific. 
The  Ability  of the  F(ab')2  Fragments  of the  Anti-CRl  Antibodies  to  Induce  Immunity  in 
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FIG.  1.  Induction of DTH  to ABA in Cy-pretreated animals with anti-CRI antibodies. Normal 
A/J  mice were either pretreated with Cy  (50  mg/kg)  (0)  or saline  (O)  2  d  before intravenous 
injection of various doses of anti-CRI antibodies. 5 d after injection, the mice were challenged with 
25/d of diazonium salt ofp-arsanilic acid in the footpad (A) and with 20 ttl of 0.2% DNFB on the 
ear (B). The increase in footpad and ear swelling was measured 24 h  after challenge. Shaded area 
represents the footpad swelling of animals challenged alone. 
suppressor T  cells in many different experiments (6, 8, 20), the F(ab')2 fragments of 
such antibodies were unable to induce suppression (6, 8, 20). We had observed that 
anti-CRI antibodies injected intravenously led to the rapid induction of suppressor T 
cells whereas, in the absence of  suppressor T-cell activation (for example Cy-pretreated 
mice), anti-CRI antibodies as shown above will then induce immunity. Experiments 
were then designed to investigate whether F(ab')2 fragments of the anti-CRI antibodies 
stimulated immunity in normal A/J mice. Animals were either pretreated with Cy or 
saline and 2 d later, were injected with various doses of the intact anti-CRI antibodies 
or  their  F(ab')2  fragments  intravenously.  Challenge  was  performed  5  d  later  as 
described above. 
The results of a  representative experiment are depicted in Fig. 2. As can be seen, 
the intact molecules of anti-CRI antibodies only induced immunity in Cy-pretreated 
animals.  However, the F(ab')2 fragments of the anti-CRI antibodies induced signifi- 
cant ABA-specific DTH in both normal and Cy-pretreated animals. 
Induction  of  ABA-specific  DTH  by  Subcutaneous  Administration  of  Anti-CRI 
Antibodies.  The route of antigen presentation plays a decisive role on the development 
of an  immune  response.  Although  subcutaneous  immunization  favors  immunity, 
intravenous injection of certain antigens induces specific nonresponsiveness to subse- 
quent immunization (24). We next investigated the ability of anti-CRI antibodies to 
induce immunity when administered subcutaneously. 
Normal A/J mice were immunized with various doses of anti-CRI antibodies either 
subcutaneously  or  intravenously.  Challenge  was  administered  5  d  later  and  the 
increase in footpad swelling measured 24 h after challenge as described above. 
The result of such an experiment is shown in Fig. 3. Whereas intravenous injection 
of anti-CRI  antibodies  failed to induce any significant immunity in the absence of 
pretreatment  with  Cy,  in  contrast,  subcutaneous  injection  of anti-CRI  antibodies 
stimulated significant levels of DTH reactivity to ABA in normal A/J animals. Thus, 900  ANTIGEN- AND  RECEPTOR-DRIVEN REGULATORY MECHANISMS 
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Fxo.  2.  The ability of the F(ab')~ fragments of the anti-CRI antibodies to induce immunity in A/ 
J mice. A/J mice were either pretreated with Cy (50 mg/kg) (O) or saline (O) 2 d before intravenous 
injection of various  doses of anti-CRI antibodies (A) or the F(ab')2  fragments  of the anti-CRI 
antibodies (B). 5 d  after injection, the mice were challenged with 25 #1 of diazonium salt of p- 
arsanilic acid in the footpad. The increase in footpad  swelling was measured 24 h after challenge. 
The shaded area represents the footpad swelling of animals challenged alone. 
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Fro.  3.  Induction of ABA-specific DTH by subcutaneous administration of anti-CRI antibodies. 
Normal A/J mice were injected with various doses of anti-CRI antibodies either intravenously or 
subcutaneously.  5 d later, the mice were challenged with 2,5 #1 of diazonium salt ofp-arsanilic acid 
in the footpad. The increase in footpad swelling was measured 24 h after challenge. 
if the  anti-CRI  antibodies  are  administered  subcutaneously  it  is  not  necessary  to 
pretreat  the animals with Cy to induce ABA-specific DTH. 
Transfer of lmmuni~ from Animals Immunized with Anti-CRI Antibodies to Naive Recipients 
is  a  T-Cell-dependent Phenomenon.  To  gain  additional  evidence  that  the  immunity 
induced with anti-CRI is a  form of delayed-type hypersensitivity we investigated the 
ability of lymph node cells taken from animals sensitized with anti-CRI antibodies to 
adoptively transfer immunity to naive recipients. 
The results depicted  in Fig. 4  revealed that  lymph node cells taken from animals 
sensitized with anti-CRI antibodies 4 d  earlier indeed can transfer immunity to naive 
recipients. In addition, pretreatment  of immune  lymph node  (LN)  cells with  anti-0 
serum  plus  complement  completely  abrogated  their  ability  to  transfer  immunity. 
Thus, successful transfer of DTH  immunity induced by anti-CRI is a T-cell-dependent 
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FIG. 4.  Transfer of immunity from animals immunized with anti-CRI antibodies to naive recipi- 
ents, is a T-cell-dependent  phenomenon.  A/J mice were immunized  with  1 ~g IBC of anti-CRI 
antibodies subcutaneously. 4 d later, draining lymph nodes were removed and single cell suspensions 
were prepared.  Before transfer  to normal recipients,  some of the cells were treated with either 
normal mouse serum or anti-0 antiserum  and complement. All recipients were challenged with 25 
/xl of diazonium salt ofp-arsanilic acid in the footpad within  1 h after cell transfer. The increase in 
footpad swelling was measured 24 h after challenge. 
Expression of Idiotype on Immune  T  Cells Induced with Anti-CRI Antibodies.  To further 
characterize the immune T  cells (TDH) responsible for the passive transfer of immunity, 
we examined the expression of idiotype on their surface. 
Immune TDH were induced in normal A/J mice by subcutaneous administration of 
anti-CRI antibodies or ABA-SC. The results are shown in Fig. 5; as can be seen, anti- 
CRI  serum  and complement  treatment  of LN cells taken  from  animals immunized 
with anti-CRI completely abrogated their ability to transfer immunity. However, the 
same antiserum  treatment  did not  interfere with  the ability of LN cells taken  from 
animals immunized with  ABA-SC to transfer  immunity.  From  these we concluded 
that a substantial fraction of immune TDH cells induced with anti-CRI bear idiotypic 
structures on their surface, whereas in contrast most of the immune TDH induced with 
ABA-SC seem to lack detectable idiotypic determinants. 
Suppressor T  Cells Induced with ABA-SC Suppress the Development of DTH Induced with 
Anti-CRI Antibodies.  To delineate whether immunity  induced with anti-CRI is also 
subjected  to  negative  regulatory mechanisms,  we  investigated  if suppressor T  cells 
induced  with  ABA-SC  inhibit  the  development  of  DTH  induced  with  anti-CRI 
antibodies. 
Suppressor T  cells were induced by intravenous injection of ABA-SC as described 
previously (23).  7 d  later they were transferred  to normal A/J  mice. The  recipients 
were  then  immunized  by  the  subcutaneous  administration  of anti-CRI  antibodies 
within  1 h  after cell transfer. The results of such  an experiment are depicted in Fig. 
6.  Animals that  received normal  spleen cells, when  immunized  with  subcutaneous 
administration of anti-CRI still exhibited significant immunity. However, in animals 
that  received  suppressor  T  cells,  anti-CRI  antibodies  failed  to  induce  significant 
immunity.  Thus  immunity  induced  with  anti-CRI  antibodies  is  also  subject  to 
negative regulatory signals mediated by idiotype-positive suppressor T  cells. 
The  Ability  of Anti-CRI Antibodies  to  Induce Immunity  is  Linked to  Igh-I  Heavy-Chain 902  ANTIGEN-  AND  RECEPTOR-DRIVEN  REGULATORY  MECHANISMS 
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Fla.  5.  Expression of idiotype on immune T  cells induced with anti-CRI antibodies. Normal A/J 
mice were immunized with 3 x  107 ABA-SC or 1 #g IBC anti-CRI antibodies subcutaneously. 4 d 
later, draining lymph nodes were removed and single cell suspensions were prepared. Before transfer 
to  naive recipients, the cells were treated with either normal  rabbit  serum  (NRS)  or  anti-CRI 
antiserum and complement. All recipients were challenged with 25/LI ofdiazonium salt ofp-arsanilic 
acid  within  1 h  after  cell  transfer.  The  increase  in  footpad  swelling was  measured  24  h  after 
challenge. 
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FIG. 6.  Suppressor T  cells induced with ABA-SC suppress the development of DTH induced with 
anti-CRI antibodies. A/J mice were injected intravenously with 5  ×  l0  7 ABA-SC. 7 d  later, they 
were the donors of suppressor T cells. 5 ×  10  7 spleen cells from such animals and 5 ×  10  7 spleen cells 
from normal A/J mice were injected intravenously into two different groups of naive recipients. All 
recipients and control animals were immunized subcutaneously with 1 ~g IBC ofanti-CRI antibodies 
within 2 h after cell transfer. 5 d later, the mice were challenged with 25/1,1 of diazonium salt ofp- 
arsanilic acid in the footpad and increase in footpad swelling was measured 24 h  after challenge. 
Allotype.  The  ability  of animals  to  manifest  an  anti-ABA  antibody  response  which 
bears CRI  determinants  is linked to the heavy-chain  Igh-1 allotype  (25). Furthermore, 
the  ability  of anti-CRI  antibodies  to  activate  suppressor  T  cells is also  linked  to  the 
heavy-chain  Igh-1  allotype  (20).  Experiments  were  designed  to examine  whether  the M.-S.  SY,  A.  R.  BROWN,  B.  BENACERRAF,  AND  M.  I.  GREENE  903 
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Fro.  7.  The  ability of anti-CRI  antibodies to induce  immunity is  linked to  Igh-1  heavy-chain 
allotype. Normal A/J (H-2", Igh- 1~), BALB/c (H-2  d, Igh- la), and C.AL20 (H-2  't, Igh-I a) mice were 
immunized with various doses of anti-CRI antibodies subcutaneously. 5 d after immunization, the 
mice were challenged with 25 #1 of diazonium salt ofp-arsanilic acid in the footpad. The increase 
in  footpad swelling was measured  24  h  after challenge. The shaded area  represents the footpad 
swelling of animals challenged alone. 
capacity of anti-CRI antibody to induce immunity is also linked to the same genetic 
locus. 
The results are shown in Fig.  7. Anti-CRI antibodies induce significant immunity 
in both A/J and C.AL20 mice. However, the same amount of anti-CRI  antibodies 
administered to BALB/c mice was unable to induce any detectable immunity. Thus, 
similar  to  the  observation  that  the  activation  of suppressor  T  cells  is  genetically 
restricted (20), the inheritance of the ability to respond to anti-CRI antibodies with 
the development of ABA-specific DTH is also linked to the heavy-chain Igh-1 allotype 
locus. 
Discussion 
The results presented in this and a previous communication (90)  address the issue 
of activation of distinct subsets of hapten-specific T cells using anti-idiotypic antibod- 
ies.  In  summary,  it  is  possible  to induce different effector T-cell functions namely 
suppressor T  cells  CI'8) and  Ttm with  anti-idiotypic antibodies  under  appropriate 
experimental conditions. The observation that intravenous injection of anti-idiotypic 
antibodies induces immunity only in Cy-pretreated animals is in accordance with our 
earlier findings that anti-idiotypic antibodies were unable to manifest their suppressive 
effect in  Cy-pretreated animals  (20).  These results were interpreted to reflect  that 
under normal conditions the intravenous injection of anti-idiotypic antibodies at the 
appropriate dose always preferentially activated suppressor T  cells. However, in the 
relative absence of an essential Cy-sensitive cell in the suppressor T-cell circuit, pre- 
TDH effector cells will be activated. This observation in some respects is very similar 
to  the  recent  findings  of  Ptak  et  al.  (26).  These  investigators  observed  in  the 
trinitrophenol contact sensitivity system, that intravenous injection of hapten-coupled 
cells  will  preferentially  activate  suppressor  T  cells  as  shown  previously  (23,  27). 
However, if the animals  had been pretreated with Cy, the intravenous injection of 
hapten-coupled cells was found to induce immunity rather than suppression. 
Furthermore, from the dose-response studies described herein, it became obvious 
that the optimal dose of anti-idiotypic antibodies required for the induction of DTH 
is 10-fold lower than the one necessary for the induction of suppressor T  cells (20). 904  ANTIGEN-  AND RECEPTOR-DRIVEN REGULATORY MECHANISMS 
The ability of exogenous anti-idiotypic antibodies to induce effector T  and/or B 
cells has been investigated in many experimental systems (4-9). The elegant works of 
Eichmann (6, 7) demonstrated that depending on the isotype of anti-idiotypic xeno- 
antibodies  employed, one can  either activate suppressor T  cells or helper T  cells. 
Passive administration of the IgG1 fraction of the guinea pig anti-idiotypic antibodies 
was  found to induce helper T  cells, whereas injection of the IgG2 fraction induced 
suppressor T  cells  in  mice.  However, in  our studies  intravenous  injection of anti- 
idiotypic antibodies was always found to activate suppressor T  cells unless suppressor 
T-cell precursors had been eliminated first. It should be noted that the anti-idiotypic 
antibodies employed in our studies are raised  in rabbit, whereas the anti-idiotypic 
antibodies used in Eichmann's study were of guinea pig origin. The ability of anti- 
idiotypic antibodies to induce DTH has also been suggested earlier. Julius and his co- 
workers (28) found that the injection of low doses of anti-T 15 antibodies to T 1.5  + mice 
is able to induce phosphorylcholine-specific DTH. 
One of the most  interesting observations documented herein is derived from the 
studies using F(ab')2 fragments of the anti-idiotypic antibodies to induce DTH. It was 
found that the intravenous injection of the F(ab')2 fragments of anti-idiotype induced 
immunity in normal or Cy-pretreated animals.  As previously reported, this reflects 
the  inability of the  F(ab')2  fragment  to induce suppressor T  cells  (6,  8,  20).  Once 
again in the absence of suppressor T  cells, TDH will be activated by the appropriate 
signal. The mechanism responsible for activation of  suppressor T cells possibly requires 
a  signal mediated by intact Fc-bearing molecules, whereas induction of TDH can be 
achieved with the F(ab')2 fragment. Moreover, recent results from our laboratory have 
provided indirect evidence that activation of suppressor T  cells probably requires the 
participation of yet another undefined population of lymphocytes, whereas activation 
of TDH  does  not.  2 These  disparate  observations  may  then  reflect  a  fundamental 
difference in the activation of suppressor T  cells and T  cells which mediate DTH. 
This differential induction of distinct effector T-cell functions has also been reported 
in  the  A5A  system.  Eichmann  and  his  colleagues  (29)  had  found that  the  intact 
molecules of IgG2 anti-A5A antibodies will  induce suppressor T  cells, whereas  the 
F(ab')2 fragments of the same antibodies induce helper T  cells. 
In addition to pretreatment with Cy or using the F(ab')2 fragments of anti-idiotypic 
antibodies,  we  also  found that  subcutaneous  injection of anti-idiotypic antibodies 
induces immunity in normal mice. It is now well established that the outcome of an 
immunological  response  depends  critically on  the  route of immunization  and  the 
status of the host (30). The mechanisms that favor the induction of suppressor T  cells 
when antigen is given intravenously is most likely related to the anatomical segregation 
of antigen in the spleen after antigen administration. Because the spleen has been the 
major source of suppressor T  cells (31, 32), it is logical to postulate that intravenous 
injection of antigen will preferentially activate suppressor T  cells. On the other hand, 
subcutaneous  immunization  tends  to  favor  the  accumulation  of antigen  in  the 
draining lymph nodes, which thus predispose to the generation of DTH immunity 
(24). 
The  observation  that  immunity  induced  with  anti-idiotypic  antibodies  can  be 
transferred to naive recipients and successful transfer of immunity is a T-cell-depend- 
ent phenomenon provides direct evidence that immunity induced with anti-idiotypic 
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anti-idiotypic antibodies can be lysed with anti-idiotypic antiserum and complement 
treatment.  In  contast,  TDH  cells  induced  with  ABA-SC  are  resistant  to  similar 
treatment within the sensitivity of our methods. Thus immune TDn cells induced with 
ABA-SC appear to lack idiotypic structures, whereas TDH induced with anti-idiotypic 
antibodies do bear idiotype on their surface. 
Therefore, it is possible to induce ABA-specific TDn cells either expressing or lacking 
idiotypes  depending  on  the  form  of antigen  administered.  The  observation  that 
certain  types of immune TDH  induced by hapten-coupled cells lack  idiotype is  in 
accord with the recent findings of Sherman et al.  (33). Using an identical immuni- 
zation  protocol,  it  was  found  that  killer T  cells  (To)  induced  with  subcutaneous 
injection of ABA-SC  also  failed to exhibit  idiotypic markers.  However, other TDn 
cells  functionally  expressing  idiotype  were  observed  in  a  recent  study  from  our 
laboratories (34). In another system, it was found that immune TDH induced in Cy- 
pretreated animals with hapten protein conjugates (NP-BGG) in complete Freund's 
adjuvant (CFA) do exhibit specificities controlled by VH genes. Similarly, preliminary 
studies using ABA-KLH in CFA to induce ABA-specific DTH with identical protocols 
have revealed that TDH induced in A/J mice in such a manner may also bear idiotypic 
markers on their surface.  2 Other than the form of antigen used in immunization, we 
would  also  like  to  emphasize  that  the  expression  of idiotype-positive T  cells  also 
depends critically on  the particular T-cell subpopulation  being examined.  For ex- 
ample, it was found that intravenous injection of ABA-SC will activate suppressor T 
cells, which express idiotype determinants on their surface.  2 The suppressive function 
can be completely abrogated by in vitro treatment with anti-idiotypic antibodies and 
complement.  2 Furthermore,  Binz  et  al.  (12)  had  also  provided  evidence that  two 
subgroups of T  lymphocytes involved in the induction of cell-mediated lympholysis 
may also express entirely distinct spectra of idiotypes. 
The observations that  idiotype positive TDH can  be suppressed  by suppressor T 
cells induced with ABA-SC which also bear idiotype raised a  fundamental question 
regarding  the  role of idiotype-governed interactions  in  the  regulation  of immune 
response.  In  terms of T- and  B-cell cooperation, it  has  been shown  that  idiotype- 
positive B cells can be activated by idiotype-positive T  cells by virtue of anti-idiotype 
antibody or antigen bridging (28, 35). Furthermore, there is also evidence indicating 
that T-T interactions in certain circumstances are also governed by Ig-linked genes 
that  control  expression  of VH-like  structures  on  T  cells  (36).  However,  we  must 
account for the fact that idiotype  + suppressor T  cells induced with ABA-SC suppress 
ABA-specific DTH  reactivity irrespective of whether the  effector TDn  is  idiotype- 
positive or negative;  it appears  that  the suppression  is antigen-specific rather than 
idiotype-specific. Nevertheless, recent experiments suggest that the ability of these Ts 
to inhibit ABA DTH is allotype restricted (M.-S. Sy and M. I. Greene. Unpublished 
results.). 
Moreover,  we  have  documented  in  the  ABA  system  that  anti-idiotype-specific 
suppressor T  cells induced  by the  administration  of CRI-coupled spleen cells can 
suppress ABA-specific DTH elicited by immunization with ABA-SC  (37), although 
we have observed that the effector TDH cells resulting from this response are idiotype- 
negative.  These apparent  contradictions could be explained by  (a)  the presence of 
idiotype in the precursors of the DTH effector cells, (b) the requirement for idiotype- 
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small  amounts  of idiotype-positive anti-ABA  antibody concomitantly produced  to 
bind with the TDH cells after their interaction with antigen. 
In addition, it is also possible that the suppressor circuit requires the participation 
of another population of T  ceils.  The requirement for the presence of another T-cell 
subpopulation other than suppressor T  cells and TDH cells in order for suppression to 
occur has been demonstrated in a very similar DTH system. In contact sensitivity to 
DNFB,  it was  found that  in order for DNP-specific suppressor T  ceils to manifest 
their suppressive activities, the participation of another population of T  cells termed 
auxiliary T  cells (Ts-aux) is required. These T~-aux could be distinguished from TDn 
cells by their sensitivity to adult thymectomy and the presence of I-J region markers 
on the cell surface (38).  It is possible that the interaction between T~ and T~-aux may 
be idiotype-specific whereas  the expressed suppression  is  antigen  specific, a  notion 
similar in many respects to that discussed by Eardley et al. (36). Experiments are now 
in  progress to determine whether the expression of ABA-specific suppressor T  cells 
also  require Ts-aux,  and  furthermore if the  interaction between Ts  and  T~-aux  is 
idiotype-specific. 
In terms of idiotype anti-idiotype interactions, we would also like to stress that anti- 
idiotypic antibodies appear to induce two distinct types of T~ in vivo (39). In previous 
studies,  Nisonoff and  colleagues have  found that  A/J  mice hyperimmunized with 
antigen and suppressed with anti-idiotypic antibodies develop "Is with putative anti- 
idiotypic structures  (19).  That  is,  these  T~  bind  idiotype-coupled erythrocytes.  In 
similar studies we found that anti-idiotype induced a suppressor T  cell with idiotypic 
structures  on  its  surface.  2 To  address  this  issue  in  more  detail  we  have  recently 
established  that  suppressor  factors which  are  idiotype positive and  obtained  from 
idiotype bearing T~, when injected into normal mice, induce a second order suppressor 
(termed  T~2) (40),  which  cannot  be  lysed  by  anti-idiotypic  antibodies. 2  Hence, 
mutually  stimulating  sets  of T  cells  consisting  of those  bearing  idiotype or  anti- 
idiotype structures are generated in the murine host responsive to ABA. With this in 
mind it is indeed possible that other T-cell participants generated as a  consequence 
of anti-idiotype stimulation occur but have not as yet been evaluated. 
Furthermore, TDH can only be induced with anti-idiotypic antibodies in animals 
which possess the relevant heavy chain allotype (Igh-1). Antibodies to the major cross- 
reactive idiotype associated with  anti-ABA antibodies  in  A/J  mice were unable  to 
induce  ABA-specific DTH  in  BALB/c mice  (H-2  d,  Igh-la).  Such  antibodies  were, 
however, fully capable of inducing ABA DTH in the allotype congeneic C.AL20 mice 
which has an allotype (Igh- 1  a) similar to that ofA/J (Igh- 1  e) on a BALB/c background 
and  which  produced  humoral  antibodies  with  CRI.  Another issue  which  must  be 
addressed is the well-studied specificity for I region-coded antigens in addition to their 
specificity for the immunizing antigen displayed by antigen-induced TDH cells, which 
reflects the specificity of antigen presentation. It is important to determine whether 
anti-idiotype-induced TDH also display similar type of MHC restriction, both at the 
stage of sensitization and elicitation of the reaction. This raises the issue whether the 
anti-idiotype antibody stimulates  TDH  directly or after presentation  by Ia-bearing 
macrophage. This is an area for further exploration. 
In conclusion, these results stress the possibility of activating distinct subsets of T 
cells by using anti-receptor antibodies capable of binding to serologically definable 
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Summary 
Delayed-type hypersensitivity  (DTH)  to p-azobenzenearsonate  (ABA)  can be in- 
duced in A/J mice with intravenous injection of minute amounts of anti-cross-reactive 
idiotypic  (CRI)  antibodies,  providing  that  the  animals  have  been  pretreated  2  d 
earlier with low doses of cyclophosphamide (50 mg/kg). However intravenous injec- 
tion of the F(ab')z fragments of the anti-CRI antibodies or subcutaneous administra- 
tion with anti-CRI antibodies induces comparable immunity in both cyclophospha- 
mide-pretreated  and  normal  nontreated  animals.  Furthermore  adoptive  transfer 
experiments indicate that lymph node cells taken from animals sensitized with anti- 
CRI  4  d  earlier can  adoptively transfer  immunity  to  naive  recipients.  Transfer of 
immunity is mediated by a population of thymus-dependent  (T) cells, which express 
idiotypic structures  on  their surface.  Treatment  of effector cells with  either anti-0- 
serum or anti-idiotypic antibodies plus complement completely abrogated their ability 
to transfer immunity. In addition  idiotype-bearing suppressor T  cells induced  with 
ABA-coupled spleen cells inhibit the development ofABA-specific DTH induced with 
anti-CRI antibodies. 
Genetic analysis revealed that the ability of anti-CRI antibodies to induce ABA- 
specific DTH was linked to Igh-1 heavy-chain allotype. Anti-idiotypic antibodies to 
the  major CRI  associated  with  anti-ABA  antibodies  in  A/J  mice failed  to  induce 
significant immunity in BALB/c mice (H-2  d, Igh-la). Nevertheless, they were able to 
induce significant  immunity in C.AL20  mice (H-2  d, Igh-1  d)  which  possess a  heavy- 
chain allotype similar to that of A/J mice. 
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